2nd Annual Biomarker Conference

Scheduled For: Monday, February 6th, 2017 View all Events

Date: February 6-7, 2017

 

Website: Biomarker Conference

 

Location: San Diego, CA

 

Session Chair: Kamala Maddali, DVM, Ph.D.
Vice President, Biopharma Collaborations and Companion Diagnostics
Cancer Genetics, Inc.

 

Speaker Presentation:

 

 

CGIX on Immuno-Oncology

  • Biomarker evaluation in Solid and hematologic cancers: value of a focused vs. broad approach; role in multi-modality testing, including NGS gene panels
  • Biomarker test development in clinical trials translated into clinical practice
  • Insights into immunotherapy biomarker testing, especially PD-L1 IHC

TuDung Nguyen, Medical Director, CGI-West, Cancer Genetics, Inc.

 

Panel Discussion:

 

Complementary Diagnostics v/s Companion Diagnostics – How Do We Ensure Success in Biomarker Efforts?

  • Different aspects of biomarker development to be considered
  • Regulatory hurdles
  • Ensuring success in biomarker efforts

Kamala Maddali, VP Biopharma Collaborations and Companion Diagnostics, Cancer Genetics, Inc.

 

Speaker Presentation:

 

Challenging Factors in Immuno-Oncology Clinical Trial Studies

  • Examine the complexity of IO studies across CART/GITR/PD-L1/STING drug targets
  • Explore scientific strategy, validation, and trial management of PD-L1 focused studies across multiple indications
  • Case study on successful partnership between lab CRO and IO pharma partner

Rob Fannon, VP Biopharma Solutions, Cancer Genetics, Inc.

Meet With Us

Meet With Us

We would like to hear from you. Please complete the form below to arrange a meeting with one of our leaders during the conference to talk with you and discuss solutions to your central laboratory and biomarker service needs.

First
Last
:
Sending